![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 34, 24094-24099, August 20, 1999
§,
,
,
From the
Kimmel Cancer Center, Thomas Jefferson
University, Philadelphia, Pennsylvania 19107, ¶ The Hospital for
Sick Children, Program in Cell Biology, Toronto, Ontario M5G 1X8,
Canada, and
The Hanson Center for Cancer Research, Institute of
Medical and Veterinary Sciences, Adelaide, South Australia 5000
| |
ABSTRACT |
|---|
|
|
|---|
We have utilized the yeast two-hybrid system to
identify proteins interacting with mouse Grb10, an adapter protein
known to interact with both the insulin and the insulin-like growth
factor-I receptors. We have isolated a mouse cDNA clone containing
the C2 domain of mouse Nedd4, a ubiquitin protein ligase (E3) that also
contains a hect (homologous to the E6-AP
carboxyl-terminus) domain and three WW domains.
The interaction with Grb10 in the two-hybrid system was confirmed using
the full-length Nedd4, and it was abolished by deleting the last 148 amino acids of Grb10, a region that includes the SH2 domain and the
newly identified BPS domain. The interaction between Grb10 and Nedd4
was also reproduced in vivo in mouse embryo fibroblasts,
where endogenous Nedd4 co-immunoprecipitated constitutively with both
the endogenous and an overexpressed Grb10. This interaction was
Ca2+-independent. Grb10 interacting with Nedd4 was not
ubiquitinated in vivo, raising the possibility that this
interaction may be used to target other proteins, like tyrosine kinase
receptors, for ubiquitination.
Grb10, originally isolated using the CORT technique with the
epidermal growth factor receptor (1), is a member of a family of
adapter proteins that include at least seven isoforms in human and
mouse. Grb10 was recently identified in our laboratory and in several
others as an interacting partner with the IGF-I receptor (IGF-IR)1 (2, 3), the insulin
receptor (4-8), or both (9). All Grb10 isoforms contain a highly
conserved SH2 domain at the C terminus, a pleckstrin homology domain in
the central region and a less conserved N terminus, containing
proline-rich sequences considered possible binding sites for SH3
domain-containing proteins (7, 10). Recently, another functional domain
of the Grb10 protein has been identified and called BPS
(between the pleckstrin homology and
SH2 domains) domain (11).
The function of the different Grb10 isoforms is not fully elucidated
and the data available are also partially discordant. We showed an
inhibitory effect of mGrb10 (1) on IGF-I-mediated mitogenesis (12). An
inhibitory effect on IR signaling was also reported with a human
isoform (4), but O'Neill et al. (9) reported opposite
results on IGF-IR and IR signaling with another human variant. The most
likely explanation of these data is that different isoforms may have
different functions and may compete for common substrates. Recently,
Grb10 has been identified as a maternally expressed imprinted gene
(Meg) on mouse chromosome 11 (13), and it has been suggested that it
may be a candidate gene for the Silver-Russell syndrome in humans. More
recently, the hGrb10 SH2 domain has been shown to interact with both
the Raf1 and MEK1 kinases, and these interactions were
phosphotyrosine-independent (14). Grb10 has been also reported to
interact with the growth hormone receptor (15), the ELK receptor (16),
and BCR-ABL tyrosine kinase (17).
To identify other proteins that interact with Grb10, we used the yeast
two-hybrid system (18) to screen a mouse embryo library (19) with
full-length mGrb10 as a bait (see "Experimental Procedures"). We
isolated a cDNA encoding the C2 domain of mouse Nedd4
(neuronal precursor cell-expressed
developmentally down-regulated 4) (20, 21).
Nedd4 is a ubiquitin protein ligase (E3) containing also three WW
domains (22) involved in protein-protein interactions with proline-rich
PY motifs (23) and a hect (homologous to the E6-AP carboxyl-terminus) domain
bearing homology to a ubiquitin protein ligase (E3) enzyme (24). Using
the deletion mutant of Grb10 in the two-hybrid system we show here that
both the SH2 domain and the BPS domain of Grb10 are responsible for the
binding to the C2 domain of Nedd4, with stronger binding mediated by
the SH2 domain. The interactions of mGrb10 and Nedd4 was confirmed in vivo in mouse embryo fibroblasts using
co-immunoprecipitation experiments which showed that the endogenous
Nedd4 forms a constitutive, Ca2+-independent complex with
Grb10, and this interaction is phosphotyrosine-independent. Grb10 was
not ubiquitinated in vivo (25), raising the possibility that
by interacting with Grb10, Nedd4 may come in contact with other
proteins such as growth factor receptors and target them for ubiquitination.
Yeast Two-hybrid System--
pRK5-Grb10 plasmid (a kind gift
from Dr. Ben Margolis) was cut with HindIII, treated with
Klenow, and then cut with SacI. The purified fragment,
containing the full-length coding sequence for mGrb10, was cloned in
the GAL4 DNA-binding domain of the pAS2-1 yeast cloning and expression
vector, digested with SmaI (CLONTECH). The Y190 yeast strain (26) was first transformed with pAS2-1/Grb10 plasmid, tested for the expression of the hybrid protein by Western blotting using antibodies against the Gal4 DNA-binding domain (CLONTECH), and then transformed with a mouse
embryo cDNA library, cloned in pVP16 vector (a kind gift of Drs.
Stanley Hollenberg and Ann Vojtek (19)). Co-transformants were plated
onto -Trp-Leu-His selective medium, supplemented with 25 mM
3-aminotriazole. His+ colonies were then assayed for
Grb10 Deletion Mutants Bait Plasmids--
The mGrb10 1-473
( Other Yeast Plasmids--
The full-length Nedd4 was created by
cutting the SpeI/ApaI fragment from pBS-Nedd4 and
cloning into the SpeI/ApaI sites of pGAD-GH AD
yeast vector. The interactions were then analyzed transforming the
baits alone or co-transforming baits and preys plasmid into Y187 yeast
strain and testing the colonies for Cell Lines--
R-/IR, R-/IR/Grb10, and p6/Grb10 cells were
previously described (12): they are all mouse embryo fibroblasts,
overexpressing Grb10 (R-/IR/Grb10 and p6/Grb10); R-/IR/Grb10 and
p6/Grb10 cells overexpress, also the same number of the insulin
(R-/IR/Grb10) or the IGF-I receptor (p6/Grb10), respectively (12).
Immunoprecipitation and Immunoblotting--
Cells lysates of
exponentially growing cells (1 mg of protein) were immunoprecipitated
in HNTG buffer (20 mM Hepes, pH 7.5, 150 mM
NaCl, 0.1% Triton X-100, 10% glycerol, 0.2 mM sodium
orthovanadate, 0.2 mM phenylmethylsulfonyl fluoride, 2 mg/ml aprotinin) with the following antibodies. For Grb10 with a
monoclonal antibody against the Myc tag (Oncogene Science), for Nedd4
with polyclonal antibodies as described (21). The immunoprecipitates
were resolved by SDS-PAGE and transferred to a nitrocellulose filter.
The membranes were then probed with an anti-Grb10 polyclonal antibody
(number 309; a kind gift of Dr. Ben Margolis), anti-Nedd4 polyclonal
antibody (20), or anti-phosphotyrosine antibodies (Transduction
Laboratories), followed by incubation with horseradish
peroxidase-conjugated goat anti-rabbit IgG (Oncogene Science), or
protein A-horseradish peroxidase-linked (Amersham Pharmacia Biotech
instructions). Blots were then developed with the ECL system according
to the manufacturer's instruction (Amersham Pharmacia Biotech).
Ca2+-dependent Co-immunoprecipitation
Experiments--
These experiments were performed as described by
Plant et al. (27) with some modifications. Briefly R-/IR
cells overexpressing mGrb10 were starved for 24 h in
Ca2+-free serum-free medium (Life Technologies, Inc.),
washed twice with washing buffer (250 mM sucrose, 10 mM Hepes, pH 6.8, 1 mM EDTA), and then
incubated in Ca2+-free medium (140 mM NaCl, 6 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, 20 mM glucose, and 20 mM
Hepes) in the presence or absence of 1.1 mM
CaCl2 and 1 µM ionomycin (Calbiochem) for 5 min at 37 °C. Ionomycin in the presence of calcium has been shown
previously to increase levels of cytosolic calcium (27-29). The cells
were then washed twice with Ca2+-free medium
( Growth Factor Stimulation--
R-/IR/Grb10 and p6/Grb10 cells
were serum starved for 72 h and then stimulated with 100 ng/ml
insulin (Sigma) (R-/IR/Grb10) or 50 ng/ml IGF-I (Life Technologies,
Inc.) (p6/Grb10) for 10 min at 37 °C. Cells were then lysed and
immunoprecipitated as described above.
Detection of Ubiquitination in Vivo--
This method has been
described in detail by Staub et al. (25). Briefly
R-/IR/Grb10 or p6/Grb10 cells overexpressing Grb10 were transiently
transfected with a plasmid encoding His-tagged ubiquitin (His-Ub),
expressing eight His-tagged ubiquitin molecules under the control of a
cytomegalovirus promoter (30). 48 h after Ca2+-phosphate transfection, cells were lysed in lysis
buffer containing 50 µM
N-acetyl-L-leucinyl-L-leucinyl-L-norleucynal
(LLnL) and incubated with Ni2+-NTA-agarose beads (Qiagen)
on a rotating wheel for 4 h at 4 °C. The beads containing the
histidinated (hence ubiquitinated) bound proteins were washed twice
with HNTG plus imidazole and three times with lysis buffer and bound
proteins were than separated on 8% SDS-PAGE, transferred to a
nitrocellulose filter and probed with anti-Grb10 antibodies as
described previously. Alternatively, an eight HA-tagged ubiquitin
molecule expressing construct was transfected into cells overexpressing
Grb10 and IGF-1R (p6/Grb10) and following immunoprecipitation with
anti-Grb10 proteins were immunoblotted with anti-HA antibodies to
detect ubiquitinated proteins.
Grb10 Interacts with Nedd4 in the Two-hybrid System--
We used
mGrb10 (1) as a bait to screen a mouse embryo library (19) in the yeast
two-hybrid system (18). One of the cDNA clones isolated (see
"Experimental Procedures") encoded the N-terminal portion of mouse
Nedd4 (20), spanning the entire C2/CaLB (calcium lipid binding) domain
(31, 32), from amino acid residue 65 to 237. A full-length Nedd4 was
then used to confirm this interaction: as shown in Fig.
1, Grb10 strongly interacts with the
full-length Nedd4 (amino acids 1-887), confirming the specificity of
the interaction. In addition, no mGrb10 and Nedd4 Interact in Mammalian Cells--
To confirm these
data in mammalian cells, we performed a series of
co-immunoprecipitation experiments in mouse embryo fibroblasts (R-/IR)
or in mouse embryo fibroblasts overexpressing mGrb10 fused to a Myc tag
(R-/IR/Grb10) (12). In addition to Grb10, these cells express high
levels of endogenous Nedd4 (Fig. 2,
panel A). Thus, exponentially growing cells were lysed and
immunoprecipitated with an anti-Myc antibody. As shown in Fig. 2,
panel A, Grb10 was immunoprecipitated by Myc antibodies in
R-/IR/Grb10 cells, while no Grb10 protein was detectable in R-/IR cells
used as a control. Grb10 was clearly able to co-immunoprecipitate the
endogenous Nedd4 expressed in R-/IR/Grb10 cells. No Nedd4 protein was
detectable in immunoprecipitated R-/IR cells, confirming the
specificity of Myc antibodies for the tagged Grb10. The same experiment
was then repeated using Nedd4 antibodies: the endogenous Nedd4 (Fig. 2,
panel B, overexposed to visualize the co-immunoprecipitated proteins), is co-immunoprecipitating both the overexpressed Myc-tagged Grb10 in R-/IR/Grb10 cells and the endogenous Grb10 present in the
R-/IR cells. This experiment demonstrates that endogenous Nedd4 forms a
complex with endogenous Grb10 (or with heterologously expressed Grb10)
in living cells, suggesting the two proteins likely interact with each
other under physiological conditions.
The Nedd4/Grb10 Interaction is Ca2+-independent and
Phosphorylation-independent--
Because the C2 domain of Nedd4 has
been demonstrated to target Nedd4 to the plasma membrane in response to
Ca2+ (27), we investigated whether Ca2+ also
plays a role in the interaction between Grb10 and the Nedd4-C2 domain.
To this end, we performed a series of co-immunoprecipitation experiments in R-/IR cells overexpressing Grb10, starved in
Ca2+- and serum-free medium and then stimulated with
Ca2+ in the presence of ionomycin (see "Experimental
Procedures"). We routinely observed a slightly decreased
immunoprecipitation of both Grb10 and Nedd4 by the respective
antibodies in the presence of increasing Ca2+
concentrations, correlating with a decrease in the amount of the
co-immunoprecipitating proteins (for Nedd 4 protein in panel D, this is more evident in a shorter exposure of the film). This is probably due to a reduced affinity of the antibodies or reduced efficiency of the immunoprecipitation in the presence of increasing Ca2+ concentrations. Taking that into account our results
show that there was no significant difference in the level of Grb10 and Nedd4 co-immunoprecipitating in the presence or absence of
Ca2+ plus ionomycin treatment (Fig.
3 panels C, D, and
E). Moreover, tyrosyl-phosphorylation of Nedd4 did not seem
to be affected by increasing Ca2+ concentrations (Fig.
3C).
To further characterize the interaction between Grb10 and the C2 domain
of Nedd4, we tested whether Nedd4 co-immunoprecipitating with Grb10 is
tyrosyl-phosphorylated: thus, exponentially growing R-/IR cells
overexpressing Grb10 were immunoprecipitated with anti-Myc antibody to
precipitate Grb10, and the blot was stained with anti-phosphotyrosine
antibodies. As shown in Fig. 3 (panel A), there is a
tyrosyl-phosphorylated band migrating at the expected size of Nedd4
(lanes 1 and 2). To confirm that this band is
indeed Nedd4, the blot was stripped and reprobed with anti-Nedd4
antibodies (panel B); the Nedd4 protein (lane 1),
clearly detectable in the co-immunoprecipitation, is perfectly
overlapping with the tyrosyl-phosphorylated band shown in panel
A (lane 1), suggesting that Nedd4 was
tyrosyl-phosphorylated. However, only a small fraction of the total
phosphorylated Nedd4 protein appears to co-immunoprecipitate with
Grb10, suggesting that Grb10 may preferentially associate with the
unphosphorylated Nedd4.
To investigate if the binding between Grb10 and Nedd4 is regulated by
growth factors, we used two different cell lines overexpressing Myc-tagged mGrb10 in combination with either the insulin receptor (R-/IR/Grb10) or the IGF-IR (p6/Grb10) (12). The cells were serum-starved, stimulated with insulin (R-/IR/Grb10) or IGF-I (p6/Grb10) (see "Experimental Procedures"), and then
immunoprecipitated with either Nedd4 or Myc antibodies. As seen in Fig.
4, in both cell lines, we detected
co-immunoprecipitation of Grb10 with Nedd4 in both stimulated and
unstimulated cells. These results therefore demonstrate that the
interaction is constitutive and not modulated by growth factors. The
identity of the additional proteins immunoprecipitated by Nedd4
antibodies or co-precipitated with Nedd4 in either the insulin or the
IGF-I-stimulated cells is currently unknown. Only a small fraction of
the total Nedd4 protein appears to be tyrosine-phosphorylated either by
insulin (in R-/IR/Grb10 cells) or IGF-I (in p6/Grb10 cells), and a
tyrosyl-phosphorylated Nedd4 is detectable in the co-immunoprecipitation by Myc antibodies only after a longer exposure of the film; it is likely therefore that the majority of the Nedd4 protein is co-immunoprecipitating with Grb10 in a
phosphotyrosine-independent manner, in agreement with the data of Fig.
3, panels A and B, and the original
identification of the interaction in the yeast two-hybrid system.
Grb10 Is Not Ubiquitinated in Vivo--
Because Nedd4 is an
ubiquitin protein ligase (E3) (20, 21, 23, 24) we wanted to investigate
if Grb10, which interacts with it, is a target for ubiquitination by
Nedd4. We therefore tested whether Grb10 is ubiquitinated in
vivo, using a previously described methodology (25). Thus, we
transiently transfected R-/IR cells overexpressing Grb10 with a plasmid
encoding His-tagged multiubiquitin (30), precipitated the histidinated
(hence ubiquitinated) cellular proteins with Ni2+-agarose
beads, and immunoblotted the precipitated proteins with anti-Grb10
antibodies. As can be seen in Fig. 5, we
did not detect any ubiquitination of Grb10, despite relatively strong
ubiquitination of the To identify new interacting partners for Grb10, we performed a
yeast two-hybrid screen of a mouse embryo library (19) using mGrb10 as
a bait, and identified Nedd4 (20, 21) as a Grb10 interacting protein.
We further showed that (i) the C2 domain (31, 32) of Nedd4 is
sufficient for the interaction. (ii) A deletion of the mGrb10
C-terminal 148 amino acids, a region that includes the newly identified
BPS domain (11) and the SH2 domain, abolishes the interaction with
Nedd4. (iii) The SH2 domain alone of Grb10 shows the strongest
interaction with Nedd4 but the BPS domain alone is also able to bind
Nedd4. (iv) Grb10 and Nedd4 interact in vivo, as assessed by
co-immunoprecipitation experiments. (v) The unphosphorylated Nedd4
preferentially co-immunoprecipitated with Grb10, and this interaction
is Ca2+-independent. (vi) The interaction is constitutive
and (vii) Grb10 is not ubiquitinated in vivo in mouse embryo
fibroblasts over-expressing Grb10.
Mouse Nedd4 (20) has been shown to be expressed in a variety of
embryonic tissues and to localize in the cytoplasm (21). Nedd4 is a
ubiquitin protein ligase (E3) also containing 3 WW domains (in the
mouse) (22) and a hect domain (24). Not much is known on the biological
role of mouse Nedd4: the WW domains of rat Nedd 4 have been shown to
interact with the epithelial sodium channel (ENaC), recognizing
proline-rich PY motifs (23), while the C2 domain is mediating
Ca2+-dependent translocation to the plasma
membrane (27).
C2 domains (31, 32) encompass about 130 residues (including the calcium
lipid-binding region) (32), and usually contain 5 conserved aspartates
which provide Ca2+-binding sites (33-35). The domain has
been shown to mediate Ca2+-stimulated phospholipid and
membrane binding (27, 36). Evidence is accumulating showing that some
C2 domains can bind proteins as well (37-39): the fact that Grb10 is
interacting with Nedd4 in a Ca2+-independent manner is in
agreement with increasing lines of evidence showing that some C2
domains which are Ca2+-regulated can bind other molecules
in a Ca2+-independent manner (for a review, see Ref.
32).
The interaction between Grb10 and Nedd4 in vivo is
phosphotyrosine-independent, and is not influenced by mitogenic agents: our finding that an SH2 domain can bind a C2 domain in a
phosphotyrosine-independent manner is novel and interesting, as it
suggests an association which does not involve the binding pocket in
the SH2 domain reserved for phosphotyrosine. Other
phosphotyrosine-independent interactions with SH2 domains have already
been reported in the literature (40-43), and it has been recently
shown that the Grb10 SH2 domain can bind Raf1 and MEK1 kinases in a
phosphotyrosine-independent manner (14). How the SH2 domain of Grb10
binds the C2 domain of Nedd4 is unknown, and we cannot currently
preclude the possibility of phospholipids involvement in this
interaction, since the latter have been demonstrated to bind both SH2
and C2 domains (32, 44).
Ubiquitination of proteins usually tag them for rapid degradation (for
a review, see Ref. 45) and many lines of evidence are now accumulating
on the role of the ubiquitin-proteasome system in regulating and
degrading a number of cytosolic proteins, including cell cycle proteins
(see for review, Ref. 46). Some transmembrane proteins are
ubiquitinated as well, including several tyrosine kinase receptors like
the epidermal growth factor receptor and the platelet-derived growth
factor receptor (47, 48), and ubiquination seems to be involved in
their subsequent degradation by the endosomal/lysosomal pathway (49).
We could not detect any ubiquitination in vivo (25) of
Grb10: however, we can speculate that the interaction between Grb10 and
Nedd4 may be used to target other proteins, such as the IGF-I receptor
or the insulin receptor, for ubiquitination. The biological role of the
interaction between Grb10 and Nedd4 and a possible role of this complex
in tyrosine kinase receptors ubiquitination is currently under investigation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase activity by a filter assay as described (19).
Segregation of the bait plasmid was performed by cyclohexamide
selection (as described in CLONTECH instructions)
and confirmed by replica plating on plates lacking Leu only or lacking
both Trp and Leu, and
-galactosidase filter assay. Trp
Leu+ colonies were then mated with Y187 yeast strain,
transformed with the bait plasmid as the positive control, and with the
pLAM plasmid (CLONTECH) as the negative control and
further analyzed for
-galactosidase activity by filter assay
(19).
SH2+BPS) was constructed by cloning an
EcoRI/filled/ScaI fragment in the SmaI
site of pAS2-1. The mGrb10-SH2+BPS (amino acids 475-621) was created
inserting the EcoRI/EcoRI/filled fragment from
pSA2-1-Grb10 into the NcoI/filled site of the pAS2-1 vector.
The mGrb10-BPS (amino acids 475-518) was cloned inserting the
NcoI/NcoI/blunt fragment from pAS2-1-Grb10 into
the SmaI site of the pAS2-1 vector. The mGrb10-SH2 (amino
acids 518-621) was created inserting the
NcoI/BamHI/filled fragment from pAS2-1-Grb10 into
the NcoI/BamHI/filled site of the pAS2-1 vector.
-galactosidase activity by
filter assay.
Ca2+ conditions) or +Ca2+ medium
(+Ca2+ conditions) and then lysed in lysis buffer with or
without 1.1 mM CaCl2 and processed for
co-immunoprecipitation as described above.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase activation was
detected with the bait alone, or after co-transformation of the bait
with the AD vector alone, or between an unrelated bait (laminin) and
Nedd4 (data not shown). To localize the domain of Grb10 responsible for
the interaction, we constructed a mGrb10 bait lacking the C-terminal
148 amino acids, a region that includes the newly identified BPS domain
(11) and the SH2 domain (1). This deletion (Fig. 1) completely
abolished the interaction with the C2 domain of Nedd4, while with the
full-length Nedd4 the interaction was barely above a detectable level.
This lack of binding was not due to lack of expression of the truncated
bait, because immunoblotting with antibodies against the GAL4-binding
domain revealed stronger expression of the truncated than of the
full-length Grb10 (data not shown). To further narrow down the domain
of Grb10 responsible for the interaction with Nedd4, we constructed
three additional mGrb10 deletion mutants: one expressing the BPS domain
alone (amino acids 475-518), one expressing the SH2 domain alone
(amino acids 518-621), and one expressing both the BPS + SH2 domains
(amino acids 475-621). As shown in Fig. 1, both the BPS (amino acids 475-518) and SH2 (amino acids 518-621) domains can independently bind
Nedd4, but the SH2 domain seems to bind more strongly. The BPS+SH2
Grb10 mutant (amino acids 475-621) is interacting with Nedd4 with an
affinity comparable with the one of the SH2 alone, confirming that the
SH2 domain is likely the domain mostly responsible for the interaction.
As a control, we tested the level of expression of the deletion mutant
fusion proteins by Western blot using antibodies against the
GAL4-binding domain; our results show that the mutant proteins were all
expressed at comparable levels to the full-length mGrb10 (data not
shown). In addition, no
-galactosidase activation was detected with
any of the mutant baits alone, nor following co-transformation of the
baits with the AD vector alone (data not shown).

View larger version (34K):
[in a new window]
Fig. 1.
mGrb10 interacts with mNedd4 in the
two-hybrid system. Baits and preys were co-transformed into Y187
yeast strain and
-galactosidase activity was determined by filter
assay (see "Experimental Procedures"). The level of interaction is
defined as: ++++, very strong; +++, strong; ++, good; +, weak;
/+,
barely detectable;
, undetectable. Three colonies from
-galactosidase filter assay are presented as examples. The
numbers reported define amino acids position.

View larger version (16K):
[in a new window]
Fig. 2.
Grb10 co-immunoprecipitates in
vivo with Nedd4. Lysates from R-/IR cells or
R-/IR-Grb10 cells overexpressing Grb10 fused to a Myc tag (see
"Experimental Procedures") were immunoprecipitated (IP)
with either antibodies for the Myc tag (panel A) or
anti-Nedd4 antibodies (panel B) and probed with Grb10 and
Nedd4 antibodies. Whole cell lysates from a sample of R-/IR/Grb10 cells
was used as a control, for the correct size of the
co-immunoprecipitating proteins.

View larger version (31K):
[in a new window]
Fig. 3.
Grb10 preferentially associates in
vivo with the unphosphorylated Nedd4 and the interaction is
Ca2+-independent. Exponentially growing
R-/IR-Grb10 (1 mg) cells were immunoprecipitated with anti-Myc
antibodies (panels A and B, lane 1) and probed
with anti-phosphotyrosine antibodies (panel A) or anti-Nedd4
antibodies (panel B). Ca2+- and serum-starved
R-/IR-Grb10 cells (panels C, D, and E,
lanes 1, 3, and 5) were stimulated with
Ca2+ + ionomycin (panels C, D, and E,
lanes 2, 4, and 6) and immunoprecipitated with
anti-Nedd4 antibodies (lanes 1 and 2) or anti-Myc
antibodies (lanes 3 and 4), and probed with
anti-phosphotyrosine (panel C), Nedd4 (panel D)
or Grb10 (panel E) antibodies. Lane 2 in
panels A and B, lanes 5 and 6 in
panels C, D, and E are total cell lysates loaded
as a control.

View larger version (45K):
[in a new window]
Fig. 4.
Effect of IGF-I and insulin on Grb10/Nedd4
binding. R-/IR/Grb10 cells and p6/Grb10 cells were serum-starved
for 72 h, stimulated (see "Experimental Procedures") with
insulin (R-/IR/Grb10) or IGF-I (p6/Grb10), immunoprecipitated with
either anti-Nedd4 or anti-Myc antibodies, and then probed with
anti-phosphotyrosine, anti-Nedd4, and anti-Grb10 antibodies.
subunit of the epithelial Na+
channel (
rENaC) used as a positive control (25). These results show
that Grb10 is not ubiquitinated in vivo in exponentially growing R-/IR cells overexpressing Grb10. We repeated this experiment in p6/Grb10 cells and once again did not detect any ubiquitination of
Grb10 (data not shown).

View larger version (47K):
[in a new window]
Fig. 5.
Lack of in vivo
ubiquitination of Grb10 protein. R-/IR/Grb10 cells stably
expressing Grb10 were transiently transfected (+) or not (
) with
HA-tagged
rENaC (ENaC Tx) and/or His-ubiquitin
(His-Ub Tx). The cells were lysed and lysates were incubated
with Ni2+-NTA agarose beads (Ni2+) to
precipitate histidinated (ubiquitinated) proteins. These proteins were
separated on 8% SDS-PAGE, transferred to nitrocellulose, and blotted
with (A) anti-HA antibodies (to detect ubiquitinated
rENaC) or anti-Grb10 antibodies. Ubiquitinated species appear as a
high molecular weight smear (indicated with a bar). Lysates
represent expression of the protein.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
FOOTNOTES |
|---|
* This work was supported by Grants GM 33694 and CA 53484 from the National Institutes of Health (to R. B.) and the Medical Research Council of Canada (to D. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 215-503-4519; Fax: 215-923-0249; E-mail: morrion1@jeflin.tju.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: IGF, insulin-like growth factor; IGF-IR, IGF receptor 1; SH2, Src homology domain 2; IR, insulin receptor; PAGE, polyacrylamide gel electrophoresis; ENaC, epithelial Na+ channel.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ooi, J., Yajnik, V., Immanuel, D., Gordon, M., Moskow, J. J., Buchberg, A. M., and Margolis, B. (1995) Oncogene 10, 1621-1630[Medline] [Order article via Infotrieve] |
| 2. |
Morrione, A.,
Valentinis, B.,
Li, S.,
Ooi, J. Y. T.,
Margolis, B.,
and Baserga, R.
(1996)
Cancer Res.
56,
3165-3167 |
| 3. | Dey, B. R., Frick, K., Lopaczynski, W., Nissley, S. P., and Furlanetto, R. W. (1996) Mol. Endocrinol. 10, 631-641[Abstract] |
| 4. |
Liu, F.,
and Roth, R. A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10287-10291 |
| 5. |
Hansen, H.,
Svansson, U.,
Zhu, J.,
Laviola, L.,
Giorgino, F.,
Wolf, G.,
Smith, R. J.,
and Riedel, H.
(1996)
J. Biol. Chem.
271,
8882-8886 |
| 6. | Laviola, L., Giorgino, F., Chow, J. C., Baquero, J. A., Hansen, H., Ooi, J., Zhu, J., Riedel, H., and Smith, R. J. (1997) J. Clin. Invest. 99, 830-837[Medline] [Order article via Infotrieve] |
| 7. |
Frantz, J. D.,
Giorgietti-Peraldi, S.,
Ottinger, E. A.,
and Shoelson, S. E.
(1997)
J. Biol. Chem.
272,
2659-2667 |
| 8. | Dong, L. Q., Farris, S., Christal, J., and Liu, F. (1997) Endocrinology 11, 1757-1765 |
| 9. |
O'Neill, T. J.,
Rose, D. W.,
Pillay, T. S.,
Hotta, K.,
Olefsky, J. M.,
and Gustafson, T. A.
(1996)
J. Biol. Chem.
271,
22506-22513 |
| 10. |
Dong, L. Q.,
Du, H.,
Porter, S. G.,
Kolakowski Jr, L. F.,
Less, A. V.,
Mandarino, J.,
Fan, J.,
Yee, D.,
and Liu, F.
(1997)
J. Biol. Chem.
272,
29104-29112 |
| 11. |
He, W.,
Rose, D. W.,
Olefsky, J. M.,
and Gustafson, T. A.
(1998)
J. Biol. Chem.
273,
6860-6867 |
| 12. |
Morrione, A.,
Valentinis, B.,
Resnicoff, M.,
Xu, S.-Q.,
and Baserga, R.
(1997)
J. Biol. Chem.
272,
26382-26387 |
| 13. |
Miyoshi, N.,
Kuroiwa, Y.,
Kohda, T.,
Shitara, H.,
Yonekawa, H.,
Kawabe, T.,
Hasegawa, H.,
Barton, S. C.,
Surani, M. A.,
Kaneko-Ishino, T.,
and Ishino, F.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1102-1107 |
| 14. |
Nantel, A.,
Mohammad-Ali, K.,
Sherk, J.,
Posner, B. I.,
and Thomas, D. Y.
(1998)
J. Biol. Chem.
273,
10475-10484 |
| 15. |
Moutussamy, S.,
Renaudie, F.,
Lago, F.,
Kelly, P. A.,
and Finidori, J.
(1998)
J. Biol. Chem.
273,
15906-15912 |
| 16. |
Stein, E.,
Cerretti, D. P.,
and Daniel, T. O.
(1996)
J. Biol. Chem.
271,
23588-23593 |
| 17. | Bai, R. Y., Jahn, T., Schrem, S., Munzert, G., Weidner, K. M., Wang, J. Y. J., and Duyster, J. (1998) Oncogene 17, 941-948[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Chien, C. T.,
Bartel, P. L.,
Sternglanz, R.,
and Fields, S.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
9578-9582 |
| 19. | Vojtek, A., Hollenberg, S. M., and Cooper, J. A. (1993) Cell 74, 205-214[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Kumar, S., Tomooka, Y., and Noda, M. (1992) Biochem. Biophys. Res. Commun. 185, 1155-1161[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Kumar, S., Harvey, K. F., Kinoshita, M., Copeland, N. G., Noda, M., and Jenkins, N. A. (1997) Genomics 40, 435-443[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Bork, P., and Sudol, M. (1994) Trends Biochem. Sci. 19, 531-533[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Staub, O., Dho, S., Henry, P. C., Correa, J., Ishikawa, T., McGlade, J., and Rotin, D. (1996) EMBO J. 15, 2371-2380[Medline] [Order article via Infotrieve] |
| 24. |
Huibregste, J. M.,
Scheffner, M.,
Beaudenon, S.,
and Howley, P. M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
2563-2567 |
| 25. | Staub, O., Gautschi, I., Ishikawa, T., Breitschopf, K., Ciechanover, A., Schild, L., and Rotin, D. (1997) EMBO J. 16, 6325-6336[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Harper, J. W., Adami, G. R., Wei, N., Keyomarsy, K., and Elledge, S. J. (1993) Cell 75, 805-816[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Plant, P. J.,
Yeger, H.,
Staub, O.,
Howard, P.,
and Rotin, D.
(1997)
J. Biol. Chem.
272,
32329-32336 |
| 28. | Lang, F., Friedrich, F., Paulmichl, M., Schobersberger, W., Jungwirth, A., Ritter, M., Steidl, M., Weiss, H., Woll, E., Tschernko, E., Paulmichl, R., and Hallbrucker, C. (1990) Renal Physiol. Biochem. 13, 82-93[Medline] [Order article via Infotrieve] |
| 29. | Delles, C., Hallter, T., and Dietl, P. (1995) J. Physiol. 486, 557-569[Medline] [Order article via Infotrieve] |
| 30. | Treier, M., Staszewski, L. M., and Bohmann, D. (1994) Cell 78, 787-798[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Clark, J. D., Lim, L. L., Kriz, R., Ramesha, C. S., Sultzman, L. A., Lin, A. Y., Milona, N., and Knopf, J. F. (1991) Cell 65, 1043-1051[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Rizo, J.,
and Sudhof, T. C.
(1998)
J. Biol. Chem.
273,
15879-15882 |
| 33. | Sutton, R. B., Davletov, B. A., Berghuis, A. M., Sudhof, T. C., and Sprang, S. R. (1995) Cell 80, 929-938[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Shao, X., Davletov, B. A., Sutton, R. B., Sudhof, T. C., and Rizo, J. (1996) Science 273, 248-251[Abstract] |
| 35. | Essen, L.-O., Perisic, O., Cheung, R., Katan, M., and Williams, R. L. (1996) Nature 380, 595-602[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Nalefski, E. A., and Falke, J. J. (1996) Protein Sci. 5, 2375-2390[Abstract] |
| 37. | Sudhof, T. C., and Rizo, J. (1996) Neuron 17, 379-388[CrossRef][Medline] [Order article via Infotrieve] |
| 38. |
Ron, D.,
Luo, J.,
and Mochly-Rosen, D.
(1995)
J. Biol. Chem.
270,
24180-24187 |
| 39. |
Davis, A. J.,
Butt, J. T.,
Walkers, J. H.,
Moss, S. E.,
and Gawler, D. J.
(1996)
J. Biol. Chem.
271,
24333-24336 |
| 40. | Pendergast, A. M., Muller, A. J., Havlik, M. H., Maru, Y., and Witte, O. N. (1991) Cell 66, 161-171[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Muller, A. J.,
Pendergast, A. M.,
Havlik, M. H.,
Puil, L.,
Pawson, T.,
and Witte, O. N.
(1992)
Mol. Cell. Biol.
12,
5087-5093 |
| 42. |
Cleghon, V.,
and Morrison, D. K.
(1994)
J. Biol. Chem.
269,
17749-17755 |
| 43. |
Raffel, G. D.,
Parmar, K.,
and Rosenberg, N.
(1996)
J. Biol. Chem.
271,
4640-4645 |
| 44. | Rameh, L. E., Chen, C. S., and Cantley, L. C. (1995) Cell 83, 821-830[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Ciechanover, A. (1994) Cell 79, 13-21[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Deshaies, R., J. (1995) Trends Cell Biol. 5, 428-434 |
| 47. | Galcheva-Garbova, Z., Theroux, S. J., and Davis, R., J. (1995) Oncogene 11, 2649-2655[Medline] [Order article via Infotrieve] |
| 48. |
Mori, S.,
Heldin, C., H.,
and Claesson-Welsh, L.
(1992)
J. Biol. Chem.
267,
6429-6434 |
| 49. | Hochstrasser, M. (1996) Cell 84, 813-815[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
S. Kebache, J. Ash, M. G. Annis, J. Hagan, M. Huber, J. Hassard, C. L. Stewart, M. Whiteway, and A. Nantel Grb10 and Active Raf-1 Kinase Promote Bad-dependent Cell Survival J. Biol. Chem., July 27, 2007; 282(30): 21873 - 21883. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ekberg, F. Schuetz, N. A. Boase, S.-J. Conroy, J. Manning, S. Kumar, P. Poronnik, and D. J. Adams Regulation of the Voltage-gated K+ Channels KCNQ2/3 and KCNQ3/5 by Ubiquitination: NOVEL ROLE FOR Nedd4-2 J. Biol. Chem., April 20, 2007; 282(16): 12135 - 12142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ivancic, A. M. Spuches, E. C. Guth, M. A. Daugherty, D. E. Wilcox, and B. A. Lyons Backbone nuclear relaxation characteristics and calorimetric investigation of the human Grb7-SH2/erbB2 peptide complex Protein Sci., June 1, 2005; 14(6): 1556 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nambiar, A. Mirmohammadsadegh, R. Doroudi, A. Gustrau, A. Marini, G. Roeder, T. Ruzicka, and U. R. Hengge Signaling Networks in Cutaneous Melanoma Metastasis Identified by Complementary DNA Microarrays Arch Dermatol, February 1, 2005; 141(2): 165 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Murdaca, C. Treins, M.-N. Monthouel-Kartmann, R. Pontier-Bres, S. Kumar, E. Van Obberghen, and S. Giorgetti-Peraldi Grb10 Prevents Nedd4-mediated Vascular Endothelial Growth Factor Receptor-2 Degradation J. Biol. Chem., June 18, 2004; 279(25): 26754 - 26761. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Giovannone, E. Lee, L. Laviola, F. Giorgino, K. A. Cleveland, and R. J. Smith Two Novel Proteins That Are Linked to Insulin-like Growth Factor (IGF-I) Receptors by the Grb10 Adapter and Modulate IGF-I Signaling J. Biol. Chem., August 22, 2003; 278(34): 31564 - 31573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Charalambous, F. M. Smith, W. R. Bennett, T. E. Crew, F. Mackenzie, and A. Ward Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism PNAS, July 8, 2003; 100(14): 8292 - 8297. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Arnaud, D. Monk, M. Hitchins, E. Gordon, W. Dean, C. V. Beechey, J. Peters, W. Craigen, M. Preece, P. Stanier, et al. Conserved methylation imprints in the human and mouse GRB10 genes with divergent allelic expression suggests differential reading of the same mark Hum. Mol. Genet., May 1, 2003; 12(9): 1005 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vecchione, A. Marchese, P. Henry, D. Rotin, and A. Morrione The Grb10/Nedd4 Complex Regulates Ligand-Induced Ubiquitination and Stability of the Insulin-Like Growth Factor I Receptor Mol. Cell. Biol., May 1, 2003; 23(9): 3363 - 3372. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cariou, D. Perdereau, K. Cailliau, E. Browaeys-Poly, V. Bereziat, M. Vasseur-Cognet, J. Girard, and A.-F. Burnol The Adapter Protein ZIP Binds Grb14 and Regulates Its Inhibitory Action on Insulin Signaling by Recruiting Protein Kinase C{zeta} Mol. Cell. Biol., October 15, 2002; 22(20): 6959 - 6970. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kamynina and O. Staub Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na+ transport Am J Physiol Renal Physiol, September 1, 2002; 283(3): F377 - F387. [Abstract] [Full Text] [PDF] |
||||
![]() |
Luis Del Valle, S. Enam, A. Lassak, J. Y. Wang, S. Croul, K. Khalili, and K. Reiss Insulin-like Growth Factor I Receptor Activity in Human Medulloblastomas Clin. Cancer Res., June 1, 2002; 8(6): 1822 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Harvey, L. M. Shearwin-Whyatt, A. Fotia, R. G. Parton, and S. Kumar N4WBP5, a Potential Target for Ubiquitination by the Nedd4 Family of Proteins, Is a Novel Golgi-associated Protein J. Biol. Chem., March 8, 2002; 277(11): 9307 - 9317. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jahn, P. Seipel, S. Urschel, C. Peschel, and J. Duyster Role for the Adaptor Protein Grb10 in the Activation of Akt Mol. Cell. Biol., February 15, 2002; 22(4): 979 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Richards, D. M. Klotz, M. R. Bush, D. K. Walmer, and R. P. DiAugustine E2-Induced Degradation of Uterine Insulin Receptor Substrate-2: Requirement for an IGF-I-Stimulated, Proteasome-Dependent Pathway Endocrinology, September 1, 2001; 142(9): 3842 - 3849. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dunn and L. Hicke Domains of the Rsp5 Ubiquitin-Protein Ligase Required for Receptor-mediated and Fluid-Phase Endocytosis Mol. Biol. Cell, February 1, 2001; 12(2): 421 - 435. [Abstract] [Full Text] |
||||
![]() |
P. J. Plant, F. Lafont, S. Lecat, P. Verkade, K. Simons, and D. Rotin Apical Membrane Targeting of Nedd4 Is Mediated by an Association of Its C2 Domain with Annexin XIIIb J. Cell Biol., June 26, 2000; 149(7): 1473 - 1484. |